Cargando…
Glycosylation profile and biological activity of Remicade® compared with Flixabi® and Remsima®
As biosimilars enter the market, comparisons of product quality are needed. Manufacturing differences may lead to differences in critical quality attributes, which affect efficacy. Therefore, critical quality attributes (structure and biological activity) of Remicade® and of 2 biosimilar products (F...
| Autores principales: | , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Taylor & Francis
2017
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5540080/ https://www.ncbi.nlm.nih.gov/pubmed/28640663 http://dx.doi.org/10.1080/19420862.2017.1337620 |